performed to determine the frequencies and strength of association of perinatal mortality and parity, adjusting for maternal age, race, BMI, pre-gestational diabetes, chronic hypertension, fetal sex, smoking status, and socioeconomic status. A p-value less than 0.05 was used to indicate statistical significance. RESULTS: Of 1,317,761 total deliveries, 765,995 (58.1%) were nulliparous and 551,766 (41.9%) were multiparous with one prior birth. Nulliparous women had significantly increased rates of IUFD (aOR 3.30, 95% CI 2.93-3.72) and NND (a OR 1.54, 95% CI 1.19-1.98) compared to multiparous women even after adjusting for relevant covariates. Compared to multiparous women, nulliparous women also had increased rates of small-for-gestational (SGA) age infants at <10% birth weight (aOR 1.76, 95% CI 1.72-1.79) ( Figure  1 ) and Apgars <7 at 5 minutes (aOR 2.42, 95% CI 2.27-2.57). See Table 1 for adverse neonatal outcomes. CONCLUSION: Perinatal mortality is significantly greater in nulliparous women compared to multiparous women with term deliveries. There may be a role to focus on improving maternal health to maximize physiologic adaptation. These findings suggest that lowrisk nulliparous women may require increased surveillance and future studies are needed to determine if interventions during pregnancy can improve neonatal outcomes.
performed to determine the frequencies and strength of association of perinatal mortality and parity, adjusting for maternal age, race, BMI, pre-gestational diabetes, chronic hypertension, fetal sex, smoking status, and socioeconomic status. A p-value less than 0.05 was used to indicate statistical significance. RESULTS: Of 1,317,761 total deliveries, 765,995 (58.1%) were nulliparous and 551,766 (41.9%) were multiparous with one prior birth. Nulliparous women had significantly increased rates of IUFD (aOR 3.30, 95% CI 2.93-3.72) and NND (a OR 1.54, 95% CI 1.19-1.98) compared to multiparous women even after adjusting for relevant covariates. Compared to multiparous women, nulliparous women also had increased rates of small-for-gestational (SGA) age infants at <10% birth weight (aOR 1.76, 95% CI 1.72-1.79) ( Figure  1 ) and Apgars <7 at 5 minutes (aOR 2.42, 95% CI 2.27-2.57). See Table 1 for adverse neonatal outcomes. CONCLUSION: Perinatal mortality is significantly greater in nulliparous women compared to multiparous women with term deliveries. There may be a role to focus on improving maternal health to maximize physiologic adaptation. These findings suggest that lowrisk nulliparous women may require increased surveillance and future studies are needed to determine if interventions during pregnancy can improve neonatal outcomes. Baylor University Medical Center, Dallas, TX OBJECTIVE: Women with pregestational diabetes have increased risk of poor maternal/neonatal outcomes. In addition to challenging glycemic control they are predisposed to variations in glycolysis, gluconeogenesis and fatty acid metabolism compared to their nondiabetic counterparts. There is limited data on metabolomic changes across pregnancy in diabetic patients. The objective of this study is to determine if metabolomic alterations can be detected in urine of diabetic women compared to controls longitudinally from early to late gestation. STUDY DESIGN: This is a prospective case-control study. Diabetic women and matched controls were recruited prior to 20 wks and followed longitudinally to late gestation after 32 wks. 44 urine specimens were obtained at two time points from 22 subjects. All cases were pregestational insulin dependent diabetics. Controls were matched by age, race, BMI, and GA. Proton nuclear magnetic resonance spectroscopy(1 H-NMR) was used to gain global metabolic profiles of urine. Significance of metabolites was determined using a Student's t-test of the area under the metabolite peak(s) of probabilistic quotient normalized spectra. Significant pathways were determined using overrepresentation analysis (ORA) on metabolites defined as significant following t-test. Significance was defined as p < 0.05 for metabolites and metabolic pathways. RESULTS: A Student's t-test revealed multiple metabolites and subsequent pathway analysis revealed changes in glycerophospholipid metabolism and lysine biosynthesis. Choline, phosphoethanolamine, ethanol amine as well as oxoglutaric acid, L-lysine were noted to significantly decrease as gestation advances in diabetic patients vs control subjects. CONCLUSION: This data confirms alterations in metabolomic profiles in urine of diabetic mothers longitudinally in pregnancy compared to controls. Decreases in metabolites involved in glycerophospholipid metabolism and lysine biosynthesis indicate defects in amnio amino acid synthesis and fatty acid oxidation. These alterations have been implicated in adverse pregnancy outcomes including miscarriage, demise, fasting hypoglycemia and cardiovascular collapse. Urine metabolites may provide a simple non-invasive test potentially enabling better risk stratification of women with diabetes. Further investigation is needed to evaluate varying metabolomic profiles in diabetic patients and their correlation to maternal and neonatal outcomes.
998 Maternal serum hormones of the maternal/ fetal hypothalamic-pituitary axes and its association with successful labor induction. 
